55289-784 NDC - TIZANIDINE HYDROCHLORIDE

Drug Information

Product NDC: 55289-784

Proprietary Name: tizanidine hydrochloride

Non Proprietary Name: tizanidine hydrochloride

Active Ingredient(s):
  • 4 mg/1 TIZANIDINE HYDROCHLORIDE


Administration Route(s): ORAL

Dosage Form(s): TABLET

Pharmacy Class(es):
  • Adrenergic alpha2-Agonists [MoA];
  • Central alpha-2 Adrenergic Agonist [EPC]

Labeler Information

Labeler Name: PD-Rx Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA076280
Marketing Category: ANDA
Start Marketing Date:6/27/2002
End Marketing Date:9/30/2022

Package Information

No. Package Code Package Description Billing Unit
155289-784-2020 TABLET in 1 BOTTLE, PLASTIC (55289-784-20)EA
255289-784-3030 TABLET in 1 BOTTLE, PLASTIC (55289-784-30)EA
355289-784-6060 TABLET in 1 BOTTLE, PLASTIC (55289-784-60)EA
455289-784-9090 TABLET in 1 BOTTLE, PLASTIC (55289-784-90)EA

NDC Record

Field Name Field Value Definition
PRODUCT NDC55289-784The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEtizanidine hydrochlorideThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEtizanidine hydrochlorideThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMETABLETThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE6/27/2002This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE9/30/2022This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEANDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERANDA076280This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEPD-Rx Pharmaceuticals, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMETIZANIDINE HYDROCHLORIDEThis is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH4 
ACTIVE INGRED UNITmg/1 
PHARM CLASSESAdrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 8/16/2019